HomeLTRN • NASDAQ
add
Lantern Pharma Inc
Previous close
$3.37
Day range
$3.27 - $3.43
Year range
$2.55 - $6.12
Market cap
35.73M USD
Avg Volume
56.83K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.77M | -16.71% |
Net income | -4.54M | 16.62% |
Net profit margin | — | — |
Earnings per share | -0.42 | 17.65% |
EBITDA | -4.77M | 16.73% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 19.72M | -48.59% |
Total assets | 21.10M | -46.91% |
Total liabilities | 4.32M | 8.84% |
Total equity | 16.78M | — |
Shares outstanding | 10.78M | — |
Price to book | 2.16 | — |
Return on assets | -51.15% | — |
Return on capital | -62.16% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -4.54M | 16.62% |
Cash from operations | -4.38M | -42.60% |
Cash from investing | 3.24M | 682.44% |
Cash from financing | — | — |
Net change in cash | -1.13M | 68.34% |
Free cash flow | -2.67M | -113.27% |
About
Founded
2013
Headquarters
Website
Employees
24
